샘종암종연쇄를 동반한 대장암에서 Vimentin 유전자의 프로모터 메틸화에 관한 연구
Aberrant Promoter Methylation of the Vimentin Gene in Colorectal Cancer Associated with the Adenoma-Carcinoma Sequence
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Background : DNA hypermethylation is a common epigenetic finding in human cancers and is closely associated with transcriptional silencing. In the present study, we investigated the proportion of colorectal neoplasms that showed the adenoma-carcinoma progression and vimentin gene methylation. Methods : Methylation status of the vimentin gene was examined in nontumoral mucosa, adenomas, and adenocarcinomas from 45 colorectal cancer patients who had adenoma and adenocarcinoma together. Methylation status was determined by bisulfite modification and the methylation-specific polymerase chain reaction. The expression of the vimentin gene product was also examined by immunohistochemistry. Results : Promoter methylation of vimentin was detected in 80% (36 out of 45 cases) of adenocarcinomas, 82.2% (37 of 45) of adenomas, and 28.9% (13 of 45) of normal epithelia, and the difference between neoplastic and normal specimens was statistically significant (p < 0.001). However, no significant correlations were observed between methylation frequency and clinicopathologic variables. Immunohistochemically, vimentin expression was not observed in either normal epithelial cells or tumor cells. Protein expression and vimentin promoter methylation were not associated. Conclusions : The frequency of aberrant methylation of the vimentin gene was high in colonic adenomas and adenocarcinomas. This result suggests that the methylation status of vimentin may be clinically beneficial in screening for colorectal cancer patients and may be helpful in clarifying colorectal cancer biology.
Abstract
Background : DNA hypermethylation is a common epigenetic finding in human cancers and is closely associated with transcriptional silencing. In the present study, we investigated the proportion of colorectal neoplasms that showed the adenoma-carcinoma progression and vimentin gene methylation. Methods : Methylation status of the vimentin gene was examined in nontumoral mucosa, adenomas, and adenocarcinomas from 45 colorectal cancer patients who had adenoma and adenocarcinoma together. Methylation status was determined by bisulfite modification and the methylation-specific polymerase chain reaction. The expression of the vimentin gene product was also examined by immunohistochemistry. Results : Promoter methylation of vimentin was detected in 80% (36 out of 45 cases) of adenocarcinomas, 82.2% (37 of 45) of adenomas, and 28.9% (13 of 45) of normal epithelia, and the difference between neoplastic and normal specimens was statistically significant (p < 0.001). However, no significant correlations were observed between methylation frequency and clinicopathologic variables. Immunohistochemically, vimentin expression was not observed in either normal epithelial cells or tumor cells. Protein expression and vimentin promoter methylation were not associated. Conclusions : The frequency of aberrant methylation of the vimentin gene was high in colonic adenomas and adenocarcinomas. This result suggests that the methylation status of vimentin may be clinically beneficial in screening for colorectal cancer patients and may be helpful in clarifying colorectal cancer biology.
참고문헌 (29)
- Lynch HT, "Hereditary colorectal cancer", N Engl J Med, 348, pp.919~932 (2003)
- Thiagalingam S, "Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers", Nat Genet, 13, pp.343~346 (1996)
- Baylin SB, ""Epigenetic gene silencing in cancer:a mechanism for early oncogenic pathway addiction? Nat Rev", Cancer, 6, pp.107~116 (2006)
- Esteller M, "Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis", Cancer Res, 61, pp.4689~4692 (2001)
- Harris LC, "Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene", Nucleic Acids Res, 19, pp.6163~6167 (1991)
- Kim HC, "CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer", J Gastroenterol Hepatol, 20, pp.1920~1926 (2005)
- Bloemendal H, "Intermediate filaments:known structure,unknown function", Biochim Biophys Acta, 1007, pp.245~253 (1989)
- Lodish H, "Molecular cell biology. 3rd ed" (1995), Scientific American Books
- Steinert PM, "Molecular and cellular biology of intermediate filaments", Annu Rev Biochem, 57, pp.593~625 (1988)
- Moskaluk CA, "Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections", Am J Pathol, 150, pp.1547~1552 (1997)
- Ministry for Health, Welfare, and Family Affairs, "Statistical yearbook of Ministry for Health, Welfare, and Family Affairs: cancer incidence and major cancer five-year relative survival", Ministry for Health, Welfare, and Family Affairs, ~ (2008)
- Itzkowitz SH, "Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation", Am J Physiol Gastrointest Liver Physiol, 287, pp.G7~170 (2004)
- Kim H, "Clinical and pathological significance of the genetic analysis in colorectal carcinomas", Korean J Gastroenterol, 43, pp.275~82 (2004)
- Chung DC, "The genetic basis of colorectal cancer:insights into critical pathways of tumorigenesis", Gastroenterology, 119, pp.854~865 (2000)
- Bestor TH, "Two DNA methyltransferases from murine erythroleukemia cells:purification,sequence specificity,and mode of interaction with DNA", Proc Natl Acad Sci U S A, 80, pp.5559~5563 (1983)
- Huang TH, "Methylation profiling of CpG islands in human breast cancer cells", Hum Mol Genet, 8, pp.459~70 (1999)
- Greger V, "Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma", Hum Genet, 94, pp.491~496 (1994)
- Graff JR, "E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas", Cancer Res, 55, pp.5195~5199 (1995)
- Herman JG, "Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma", Proc Natl Acad Sci U S A, 91, pp.9700~9704 (1994)
- Issa JP, "Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon", Nat Genet, 7, pp.536~540 (1994)
- Kane MF, "Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines", Cancer Res, 57, pp.808~811 (1997)
- Brenner DE, "Fecal DNA biomarkers for the detection of colorectal neoplasia:attractive,but is it feasible?", J Natl Cancer Inst, 97, pp.1107~1109 (2005)
- Chen WD, "Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene", J Natl Cancer Inst, 97, pp.1124~1132 (2005)
- Zou H, "Highly methylated genes in colorectal neoplasia:implications for screening", Cancer Epidemiol Biomarkers Prev, 16, pp.2686~2696 (2007)
- Ngan CY, "Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer", Br J Cancer, 96, pp.986~992 (2007)
- Singh S, "Overexpression of vimentin:role in the invasive phenotype in an androgen-independent model of prostate cancer", Cancer Res, 63, pp.2306~2311 (2003)
- Alfonso P, "Proteomic expression analysis of colorectal cancer by twodimensional differential gel electrophoresis", Proteomics, 5, pp.2602~2611 (2005)
- Bindels S, "Regulation of vimentin by SIP1 in human epithelial breast tumor cells", Oncogene, 25, pp.4975~4985 (2006)
- Yates B, "Promoterindependent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta", Exp Cell Res, 313, pp.3718~3728 (2007)